Fresenius Medical Care AGCHIX:FMED -2.92%69 PB Ratio is 0.83 as of Jun. 26, 2026, which is 46% below its 10-year median of 1.54. GuruFocus rates CHIX:FMED with a GF Score™ of 69/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 4 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 83.31% on this metric.
Fresenius Medical Care AG stock PB Ratio (=0.83) is close to 1-year low of 0.76.
The historical rank and industry rank for Fresenius Medical Care AG's PB Ratio or its related term are showing as below:
CHIX:FMEd'
s PB Ratio Range Over the Past 10 Years
Min: 0.51 Med: 1.54 Max: 2.87
Current: 0.83
During the past 13 years, Fresenius Medical Care AG's highest PB Ratio was 2.87. The lowest was 0.51. And the median was 1.54.
CHIX:FMEd's PB Ratio is ranked better than 83.31% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs CHIX:FMEd: 0.83
During the past 12 months, Fresenius Medical Care AG's average Book Value Per Share Growth Rate was 0.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Fresenius Medical Care AG was 13.70% per year. The lowest was -3.30% per year. And the median was 7.10% per year.
Back to Basics: PB Ratio
Fresenius Medical Care AG (CHIX:FMEd) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Fresenius Medical Care AG PB Ratio Related Terms
Fresenius Medical Care AG PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Fresenius Medical Care AG (CHIX:FMED) has a PB Ratio of 0.83 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fresenius Medical Care AG and its competitors. This is 46% below median its historical median of 1.54. Over the past decade, Fresenius Medical Care AG's PB Ratio has ranged from 0.51 to 2.87. According to the industry distribution chart, Fresenius Medical Care AG ranks #102 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 16.7%.
Is Fresenius Medical Care AG's PB Ratio too high?
Fresenius Medical Care AG's current PB Ratio of 0.83 is 46% below median its 10-year median of 1.54. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 2.87. The Healthcare Providers & Services industry median PB Ratio is 1.98. Fresenius Medical Care AG's value of 0.83 is 58.1% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #102 out of 611 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #102 out of 611 companies for PB Ratio. This places Fresenius Medical Care AG in the top 17% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Fresenius Medical Care AG's value of 0.83 is 58.1% below this benchmark. Historically, Fresenius Medical Care AG's own PB Ratio has ranged from 0.51 to 2.87 over the past decade. While the company's 10-year median is 1.54 vs. the industry median of 1.98, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current PB Ratio of 0.83 is 58.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current PB Ratio is 0.83, which is 46% below median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (CHIX:FMED) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €40.86 — trading 1% below its estimated fair value. The current PB Ratio is 0.83, which is 46% below median its 10-year median of 1.54 and 58.1% below the Healthcare Providers & Services industry median of 1.98. Fresenius Medical Care AG's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Fresenius Medical Care AG (CHIX:FMED), the current PB Ratio is 0.83 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (CHIX:FMED) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of €40.86 is trading 1% below its estimated GF Value™ of €41.29.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for CHIX:FMED:
PB Ratio: 0.83 (46% below median its 10-year median of 1.54)
GF Value™: €41.29 vs. price of €40.86 (1% below fair value)
Industry Position: 58.1% below the Healthcare Providers & Services median (#102 of 611)
No single metric tells the full story. See the CHIX:FMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
69GF Score
Get the complete analysis for CHIX:FMED
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:FMED has been successfully added to your 
